The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients

Mucosal Immunology

Volumn 9, Issue 1, 2016, Pages 265-274

  Allers, K ^a   Puyskens, A ^a   Epple, H J ^a   Schurmann D ^a   Hofmann, J ^a   Moos, V ^a   Schneider, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; KI 67 ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DUODENUM BIOPSY; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MUCOSAL IMMUNITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TIME TO TREATMENT; ACUTE DISEASE; AGED; CASE CONTROL STUDY; CELL DIFFERENTIATION; CHRONIC DISEASE; DISEASE COURSE; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; TH17 CELL; VIROLOGY;

ACUTE DISEASE; ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; TH17 CELLS; TIME-TO-TREATMENT;

EID: 84953329705     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.58     Document Type: Article

References (49)

1. Brenchley J.M., et al.CD4+ Tcell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200, 749-759 (2004
2. Mehandru S., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200, 761-770 (2004
3. Schneider, T., Jahn, H.U., Schmidt, W., Riecken, E.O., Zeitz, M., & Ullrich, R. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 37, 524-529 (1995
4. George, M.D., Sankaran, S., Reay, E., Gelli, A.C., & Dandekar, S. Highthroughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. Virology 312, 84-94 (2003
5. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006
6. Okoye A., et al. Progressive CD4+ centralmemory Tcell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 204, 2171-2185 (2007
7. Funderburg N.T., et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood 115, 161-167 (2010
8. Hunt, P.W. HIV and inflammation: mechanisms and consequences. Curr. HIV/AIDS Rep. 9, 139-147 (2012
9. Deeks, S.G., & Phillips, A.N. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338, a3172 (2009
10. Gras L., et al. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J. Acquir. Immune Defic. Syndr. 45, 183-192 (2007
11. Kelley C.F., et al. Incomplete peripheral CD4+ cell count restoration in HIVinfected patients receiving long-Term antiretroviral treatment. Clin. Infect. Dis 48, 787-794 (2009
12. Kaufmann, G.R., et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to o500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clin. Infect. Dis. 41, 361-372 (2005
13. Consolidated Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (World Health Organization, Geneva, (2013)
14. Guadalupe, M., et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003
15. Guadalupe M., et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80, 8236-8247 (2006
16. Sheth P.M., et al. Immune reconstitution in the sigmoid colon after longterm HIV therapy. Mucosal Immunol. 1, 382-388 (2008
17. Macal M., et al. Effective CD4+ T-cell restoration in gut-Associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1, 475-488 (2008
18. Talal A.H., et al. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-Associated lymphoid tissue. J. Acquir. Immune Defic. Syndr. 26, 1-7 (2001
19. Kok A., et al. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal Immunol. 8, 127-140 (2015
20. Mehandru S., et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoSMed. 3, e484 (2006
21. Ciccone E.J., et al. Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol. 3, 172-181 (2010
22. Asmuth D.M., et al. Gastrointestinal-Associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus nonnucleoside reverse transcriptase inhibitor-based regimens. AIDS 26, 1625-1634 (2012
23. Cassol E., et al. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy. J. Infect. Dis. 208, 1113-1122 (2013
24. Sathaliyawala T., et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187-197 (2013
25. Scholzen, T., & Gerdes, J. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182, 311-322 (2000
26. Sandoval-Montes, C., & Santos-Argumedo, L. CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J. Leukoc. Biol. 77, 513-521 (2005
27. Aversa, GGaH & Bruce, M. Cell Surface Markers of T-Cell Activation. Transplant Rev. 5, 22 (1991
28. Afeltra A., et al. Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann. Rheum. Dis. 52, 457-460 (1993
29. Epple H.J., et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58, 220-227 (2009
30. Allers K., et al. Effect of age on the CD4(+) T-cell impairment in HIVinfected persons without and with cART. J. Acquir. Immune Defic. Syndr. 66, 7-15 (2014
31. Verhoeven, D., Sankaran, S., & Dandekar, S. Simian immunodeficiency virus infection induces severe loss of intestinal central memory Tcells which impairs CD4+ T-cell restoration during antiretroviral therapy. J. Med. Primatol. 36, 219-227 (2007
32. Picker L.J., et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 200, 1299-1314 (2004
33. Mueller, S.N., & Ahmed, R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl Acad. Sci. USA 106, 8623-8628 (2009
34. Khaitan, A., & Unutmaz, D. Revisiting immune exhaustion during HIV infection. Curr. HIV/AIDS Rep. 8, 4-11 (2011
35. Fuller, M.J., Khanolkar, A., Tebo, A.E., & Zajac, A.J. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 172, 4204-4214 (2004
36. Mavigner M., et al. Altered CD4+ Tcell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. J. Clin. Invest. 122, 62-69 (2012
37. Estes J., et al. Collagen deposition limits immune reconstitution in the gut. J. Infect. Dis. 198, 456-464 (2008
38. Bini, E.J., Park, J., & Francois, F. Use of flexible sigmoidoscopy to screen for colorectal cancer in HIV-infected patients 50 years of age and older. Arch. Intern. Med. 166, 1626-1631 (2006
39. Bini, E.J., Green, B., & Poles, M.A. Screening colonoscopy for the detection of neoplastic lesions in asymptomatic HIV-infected subjects. Gut 58, 1129-1134 (2009
40. Emery S., et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ARTat baseline in the SMARTstudy. J. Infect. Dis. 197, 1133-1144 (2008
41. Cohen M.S., et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493-505 (2011
42. Sterne J.A., et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373, 1352-1363 (2009
43. Sereti I., et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 10, e1003890 (2014
44. Picker L.J., et al. IL-15 induces CD4 effectormemory Tcell production and tissue emigration in nonhuman primates. J. Clin. Invest. 116, 1514-1524 (2006
45. Aebischer T., et al. Correlation of Tcell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 57, 1065-1072 (2008
46. Allers K., et al. Macrophages accumulate in the gut mucosa of untreated HIV-infected patients. J. Infect. Dis. 209, 739-748 (2014
47. Allers K., et al. Gut mucosal FOXP3+ regulatory CD4+ T cells and Nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesusmacaques. J. Virol. 84, 3259-3269 (2010
48. Epple, H.J., et al. Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 139, 1289-1300 (2010
49. Allers K., et al. Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117, 2791-2799 (2011